Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Fibroma × Hydroxyurea × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Leukemia 8 Brain Neoplasms 8 Squamous Cell Carcinoma of Head and Neck 7 Leukemia, Myeloid, Chronic-Phase 7 Leukemia, Myeloid, Acute 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 7 Glioblastoma 7 Polycythemia Vera 6 Meningioma 6 Head and Neck Neoplasms 6 Gliosarcoma 5 Myelodysplastic Syndromes 4 Glioma 4 Central Nervous System Neoplasms 4 Neoplasms 3 Myeloproliferative Disorders 3 Leukemia, Myelomonocytic, Chronic 3 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3 Esophageal Neoplasms 3 Stomach Neoplasms 2 Salivary Gland Neoplasms 2 Myelodysplastic-Myeloproliferative Diseases 2 Laryngeal Neoplasms 2 Hypopharyngeal Neoplasms 2 Congenital Abnormalities 2 Treatment-Refractory Solid Tumors 1 Tongue Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Thrombosis 1 Thrombocytosis 1

Interventions

Imatinib Mesylate 2 telapristone acetate 1 seclidemstat 1 Triamcinolone Acetonide 1 Topotecan 1 Specimen Handling 1 Sirolimus 1 Nivolumab 1 Magnetic Resonance Spectroscopy 1 Ipilimumab 1 Hydroxyurea 1 Cyclophosphamide 1 CTLA-4 Antigen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00978146 2017-04-20

Effect of Hydroxyurea as Treatment for Primary Desmoid Tumors

Children's Hospital of Philadelphia

Phase 2 Withdrawn

Fibroma, Desmoid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡